WS16.03 Registry-based study of people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA): Up to 2 years of real-world outcome data

Autor: Bower, J.K., Chang, C.-Y., Sahota, G., Chin, A., Ahluwalia, N., Chu, C., Weinstock, T.G., Ostrenga, J., Regenfuß, N., Naehrlich, L.

Publikováno v: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S30-S30

Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry.

Autor: Prinz N; Institute of Epidemiology and Medical Biometry (ZIBMT), Ulm University, Ulm.; German Center for Diabetes Research (DZD), Munich-Neuherberg., Wosniok J; Interdisciplinary Centre for Clinical Trials (IZKS), University Medical Centre Mainz, Mainz., Staab D; Paed. Pneumology, Univ. Children's Hospital Charité, Berlin., Ballmann M; Pediatric Clinic, University Medicine Rostock, Rostock., Dopfer C; Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover., Regenfuß N; Interdisciplinary Centre for Clinical Trials (IZKS), University Medical Centre Mainz, Mainz., Rosenecker J; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich., Schramm D; Department of General Pediatrics, Neonatology, and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Düsseldorf., W RH; Institute of Epidemiology and Medical Biometry (ZIBMT), Ulm University, Ulm.; German Center for Diabetes Research (DZD), Munich-Neuherberg., Nährlich L; Department of Pediatrics, Justus-Liebig-University giessen, Giessen.

Publikováno v: Klinische Padiatrie [Klin Padiatr] 2020 Jul; Vol. 232 (4), pp. 210-216. Date of Electronic Publication: 2020 Mar 16.